2-[1-[(2-methoxynaphthalen-1-yl)methyl]-2-methylindol-3-yl]acetohydrazide
C23H23N3O2 — CID 15837961
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-[(2-methoxynaphthalen-1-yl)methyl]-2-methylindol-3-yl]acetohydrazide
2-[1-[(2-methoxynaphthalen-1-yl)methyl]-2-methylindol-3-yl]acetohydrazide (PubChem CID 15837961) has the molecular formula C23H23N3O2 and a molecular weight of 373.46 g/mol. Its IUPAC name is 2-[1-[(2-methoxynaphthalen-1-yl)methyl]-2-methylindol-3-yl]acetohydrazide.
Molecular Properties
| Compound Name | 2-[1-[(2-methoxynaphthalen-1-yl)methyl]-2-methylindol-3-yl]acetohydrazide |
|---|---|
| PubChem CID | 15837961 |
| Molecular Formula | C23H23N3O2 |
| Molecular Weight | 373.46 g/mol |
| Exact Mass | 373.18 |
| IUPAC Name | 2-[1-[(2-methoxynaphthalen-1-yl)methyl]-2-methylindol-3-yl]acetohydrazide |
| SMILES | COc1ccc2ccccc2c1Cn1c(C)c(CC(=O)NN)c2ccccc21 |
| InChI | InChI=1S/C23H23N3O2/c1-15-19(13-23(27)25-24)18-9-5-6-10-21(18)26(15)14-20-17-8-4-3-7-16(17)11-12-22(20)28-2/h3-12H,13-14,24H2,1-2H3,(H,25,27) |
| InChIKey | UUAPXEJWCVJYNP-UHFFFAOYSA-N |
| XLogP | 3.69 |
| TPSA | 69.28 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.46 |
| LogP ≤ 5 | 3.69 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}, {'alert_name': 'acyl_hydrazine', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15837961 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.